Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

2016 Annual Report: Top 200 Medicines

AbbVie’s biologic therapy Humira for autoimmune diseases was the worldwide prescription-drug sales leader in 2015 for the fourth consecutive calendar term.

Read More »

2016 Annual Report: State Of The Bio Industry

The outlook remains bright due to a favorable regulatory arena, support for biopharma-friendly legislation and development incentives, expanding scientific opportunities in key therapeutic areas such as immuno-oncology, and big pharma’s continued push to obtain innovation.

Read More »

2016 Annual Report: Healthcare Communications Agencies Overview – In Good Health

Long-established healthcare communications agencies in 2015 saw their businesses expand, and relative newcomers continued to find their stride.

Read More »

2016 Annual Report: Top 10 Pipelines

The pharma industry’s R&D concentration has been shifting towards specialty therapy areas as research and development returns decline for some leaders.

Read More »

Healthcare Agency Roundtable 2015

Executives from the 2015 and 2014 Manny Award winners and finalists share their views on a variety of industry-related topics.

Read More »

2015 Annual Report: Top 50 Companies Overview – Making Progress

The top pharmaceutical companies are blurring the lines with biotech and have been engaging in many collaborations, acquisitions, and restructuring plans in the past year.

Read More »

2015 Annual Report: Top 200 Medicines

Humira during 2014 remained the world’s best-selling prescription medicine; Sovaldi vaulted into second place in its first full year on the market; Harvoni is challenging Humira for the 2015 sales crown.

Read More »

2015 Annual Report: Top 100 Biotechnology Companies – The Acquisition Game

The U.S. biotechnology arena is undergoing a record-breaking M&A cycle for the industry. After generating M&A activity valued at $235 billion during 2014, the U.S. biotech sector produced more than $100 billion in deals during first-quarter 2015.

Read More »

2015 Annual Report: Healthcare Communications Agencies Overview – Growth In Unexpected Places

As the pipelines of their pharmaceutical and biotech clients continue to yield new drugs for patients, agencies are also seeing their business grow.

Read More »

2015 Annual Report: Top 10 Pipelines

Biologic medicines and immunotherapy are front and center amongst many of the R&D strategies and platforms for the industry’s leading developers.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom